文献速递肾小球疾病

从模式到蛋白质:质谱技术在肾小球疾病中的应用成熟

From Patterns to Proteins: Mass Spectrometry Comes of Age in Glomerular Disease.
PubMed 文献 · J Am Soc Nephrol · 2023-09-26

本文综述激光显微切割联合质谱(LCM/MS)在肾小球疾病中的应用,该技术已广泛用于淀粉样变性诊断分型的金标准,并在膜性肾病靶抗原发现中起重要作用,作者倡导至少在膜性肾病等特定疾病中更常规使用LCM/MS进行靶抗原检测。

要点

  • LCM/MS是淀粉样变性诊断和分型的金标准,已广泛用作临床检测。
  • LCM/MS在膜性肾病中用于靶抗原检测,作者倡导至少在特定疾病中更常规使用。
  • LCM/MS在研究方面促进了新淀粉样变性类型、纤维性GN生物标志物及补体蛋白作用的发现。

核心结论

  • LCM/MS在肾小球疾病中的作用正在扩展,当前可用于识别某些肾小球疾病的病因,未来可能在确定补体激活、炎症和纤维化通路方面发挥价值。

研究设计与样本

  • 本文为综述,讨论LCM/MS在其他肾小球疾病(特别是膜性肾病、沉积病和补体通路疾病)中的实用性。

主要发现

  • LCM/MS在识别新型淀粉样变性、纤维性GN生物标志物发现以及近期膜性肾病新靶抗原发现中起关键作用。
  • LCM/MS还证实了补体蛋白在肾小球疾病(包括C3肾小球病)中的作用。
  • LCM/MS现已广泛用作临床检测,并被认为是淀粉样变性诊断和分型的金标准。
  • 对于其余肾小球疾病,LCM/MS仍为研究工具。

临床怎么用

  • 作者倡导当前至少在特定疾病(如膜性肾病)中更常规使用LCM/MS进行靶抗原检测。
  • LCM/MS可用作淀粉样变性诊断和分型的金标准。

局限性

  • 原文述及LCM/MS的局限性,特别是从研究技术转化为临床检测所面临的困难。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Laser capture microdissection and mass spectrometry (LCM/MS) is a technique that involves dissection of glomeruli from paraffin-embedded biopsy tissue, followed by digestion of the dissected glomerular proteins by trypsin, and subsequently mass spectrometry to identify and semiquantitate the glomerular proteins. LCM/MS has played a crucial role in the identification of novel types of amyloidosis, biomarker discovery in fibrillary GN, and more recently discovery of novel target antigens in membranous nephropathy (MN). In addition, LCM/MS has also confirmed the role for complement proteins in glomerular diseases, including C3 glomerulopathy. LCM/MS is now widely used as a clinical test and considered the gold standard for diagnosis and typing amyloidosis. For the remaining glomerular diseases, LCM/MS has remained a research tool. In this review, we discuss the usefulness of LCM/MS in other glomerular diseases, particularly MN, deposition diseases, and diseases of complement pathways, and advocate more routine use of LCM/MS at the present time in at least certain diseases, such as MN, for target antigen detection. We also discuss the limitations of LCM/MS, particularly the difficulties faced from moving from a research-based technique to a clinical test. Nonetheless, the role of LCM/MS in glomerular diseases is expanding. Currently, LCM/MS may be used to identify the etiology in certain glomerular diseases, but in the future, LCM/MS can play a valuable role in determining pathways of complement activation, inflammation, and fibrosis.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Sethi S, Theis JD, Palma LMP, et al. From Patterns to Proteins: Mass Spectrometry Comes of Age in Glomerular Disease. J Am Soc Nephrol. 2023. PMID: 37749770. doi:10.1681/ASN.0000000000000221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。